Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Immune-globulin/methylprednisolone/rituximab

Lack of efficacy: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Zhang H, et al. Long-Term Prognosis of Patients With Anti-N-Methyl-D-Aspartate Receptor Encephalitis Who Underwent Teratoma Removal: An Observational Study. Frontiers in Neurology 13: 12 Apr 2022. Available from: URL: http://www.frontiersin.org/Neurology Zhang H, et al. Long-Term Prognosis of Patients With Anti-N-Methyl-D-Aspartate Receptor Encephalitis Who Underwent Teratoma Removal: An Observational Study. Frontiers in Neurology 13: 12 Apr 2022. Available from: URL: http://​www.​frontiersin.​org/​Neurology
Metadaten
Titel
Immune-globulin/methylprednisolone/rituximab
Lack of efficacy: 2 case reports
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41887-8

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Irinotecan

Case report

Multiple drugs

Case report

Multiple drug

Case report

Lenalidomide